Suppr超能文献

通过体内给予编码Fas配体的质粒DNA对实验性自身免疫性甲状腺炎进行基因治疗。

Gene therapy of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for Fas ligand.

作者信息

Batteux F, Tourneur L, Trebeden H, Charreire J, Chiocchia G

机构信息

Institut National de la Santé et de la Recherche Médicale, Unité 477, Université René Descartes, Paris, France.

出版信息

J Immunol. 1999 Jan 1;162(1):603-8.

PMID:9886438
Abstract

Fas-Fas ligand (FasL) interaction is required for the maintenance of immune homeostasis and seems to be responsible for the privileged immune status of some tissues. Experimental autoimmune thyroiditis (EAT), which is characterized by autoreactive T and B cell responses and a marked lymphocytic infiltration of the thyroid, is a model of choice to study the therapeutic effects of FasL. Here, we provide evidence that direct injection of DNA expression vectors encoding FasL into the inflamed thyroid inhibited development of lymphocytic infiltration of the thyroid and induced death of infiltrating T cells. These results were paralleled by a total abrogation of anti-Tg cytotoxic T cell response in FasL-treated animals vs controls. In summary, our results show that FasL expression on thyrocytes may have a curative effect on ongoing EAT by inducing death of pathogenic autoreactive infiltrating T lymphocytes.

摘要

Fas与Fas配体(FasL)的相互作用对于维持免疫稳态是必需的,并且似乎是某些组织具有免疫特权状态的原因。实验性自身免疫性甲状腺炎(EAT)以自身反应性T和B细胞反应以及甲状腺明显的淋巴细胞浸润为特征,是研究FasL治疗效果的理想模型。在此,我们提供证据表明,将编码FasL的DNA表达载体直接注射到发炎的甲状腺中可抑制甲状腺淋巴细胞浸润的发展,并诱导浸润性T细胞死亡。与对照组相比,FasL处理的动物中抗Tg细胞毒性T细胞反应完全消除,这些结果与之相符。总之,我们的结果表明,甲状腺细胞上的FasL表达可能通过诱导致病性自身反应性浸润T淋巴细胞死亡,对正在进行的EAT产生治疗作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验